Alzheimer's Disease
Currently available treatments for Alzheimer’s Disease address the symptoms, but do not stop the disease from progressing. A potential new treatment is being trialled using a device that delivers a specific form of ultrasound energy to regions of the brain that are affected by Alzheimer’s disease. This intervention produces an effect known as “neuromodulation”, which is an alteration of nerve activity and overall brain function. The application of ultrasound neuromodulation has been shown to enhance the communication between brain cells and to improve memory in aged animals.
The present study evaluates the safety and tolerability of the novel treatment in a small number of participants with Alzheimer’s Disease. The effects on memory and thinking abilities will also be tested. If successful, a subsequent trial will evaluate the experimental treatment in large patient cohorts to provide statistically robust evidence of safety and efficacy.